P6 Acupressure Before Laparoscopic Cholecystectomy
Postoperative ComplicationsPostoperative Nausea and VomitingThis study is to evaluate the effect of preoperative acupressure application on Postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic cholecystectomy in terms of being in high risk group for PONV.
Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment
Nausea and VomitingPostoperativePROMPT (PONV Rescue Outcomes after AMisulPride Treatment) is an observational Phase IV study designed to evaluate real-world evidence in relation to the care continuum of Post Operative Nausea and Vomiting (PONV), as well as the effectiveness and safety of common pharmacologic rescue treatment regimens compared to IV amisulpride. There will be no predefined hypothesis regarding the magnitude of efficacy or safety of various treatment regimens from the cohorts observed. We are not proposing to directly recruit patients into this study.
Olanzapine for the Treatment of Refractory Chronic Nausea and Vomiting
NauseaVomitingProspective, observational study evaluating the effect of olanzapine for the treatment of refractory chronic nausea and vomiting.
Safety of Preoperative Oral Administration of a High Caloric Drink With Protein
Postoperative Nausea and VomitingThe purpose of the study is to determine whether the oral administration of a high caloric drink with protein decreases the postoperative nausea and vomiting in patients with dysgnathia.
Immediate Nausea and Vomiting After the Administration of Non-ionic Contrast Media
Contrast AgentNauseaThe prevalence of nausea and vomiting after the administration of non-ionic contrast media has rarely been assessed. Thus, the aim of our study is to evaluate the prevalence and risk factors of nausea and vomiting after the exposure to the non-ionic contrast media for computed tomography examinations in adults.
Genetic Polymorphism and Post Operative Nausea and Vomiting (PONV)
Genetic Predisposition to DiseasePostoperative Nausea2 moreNausea and vomiting affects 25-30% of individuals in the post-operative period and can reach more than 70-80% in high-risk patients. inherited factors may play a significant role in individual susceptibility and clinical research on hereditary factors involved in the pathogenesis of Postoperative nausea and vomiting (PONV) and chemotherapy nausea and vomiting (CINV) is relatively new. The aim of this study is to investigate whether inter-individual differences related to PONV are associated with genetic factors. 300 patients will be evaluated in postoperative oncological surgeries. The peripheral leukocyte DNA will be extracted by the Salting Out Procedure method and processed to genotyping for 48 SNPs from 15 candidate genes by real-time PCR by the Taqman method. The possible associations with demographic data and factors related to surgery will be analyzed by univariate and multivariate analysis.
Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting...
NauseaVomiting1 moreObservation on acupoint electric stimulation combined with tropisetron in preventing and treating nausea and vomiting and improving the patient's appetite after TACE for primary or metastatic liver cancer patients.
Development of a Predictive Model for Post-Discharge Nausea and Vomiting (PDNV)
NauseaPostoperative Nausea and Vomiting2 moreThe primary purpose of this prospective cohort study is to develop a simplified risk model for post-discharge nausea and vomiting (PDNV) in adult same-day surgery patients in the US that will allow clinicians to identify those patients who would benefit from prophylactic antiemetic strategies.
Risk Factors for Nausea and Vomiting After Cesarean
Postoperative Nausea and VomitingInvestigators will observe the incidence of post-cesarean nausea or vomiting and try to associate it with some risk factors.
Palonosetron Associated to Aprepitant in Prophylaxis of PONV
Postoperative Nausea and VomitingThe objective of this study is to investigate if aprepitant in association with palonosetron and dexamethasone could reduce the incidence of PONV in high-risk patients for this symptom, undergoing cancer surgery mastectomies.